LARIMAR THERAPEUTICS, INC. Public Float
LARIMAR THERAPEUTICS, INC. (LRMR) had Public Float of $94.67 million as of 2025-06-30, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-19
- 2025-06-30: Entity Public Float $94.67M.
- 2024-06-30: Entity Public Float $313.61M.
- 2023-06-30: Entity Public Float $80.22B.
- 2022-06-30: Entity Public Float $20.61M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $94.67M 10-K · filed 2026-03-19 |
| 2024-06-30 | $313.61M 10-K · filed 2025-03-24 |
| 2023-06-30 | $80.22B 10-K · filed 2024-03-14 |
| 2022-06-30 | $20.61M 10-K · filed 2023-03-14 |
| 2021-06-30 | $94.40M 10-K · filed 2022-03-25 |
| 2020-06-30 | $123.30M 10-K · filed 2021-03-04 |
| 2019-06-28 | $40.10M 10-K · filed 2020-03-05 |
| 2018-06-29 | $201.80M 10-K · filed 2019-03-14 |
| 2017-06-30 | $64.90M 10-K · filed 2018-03-09 |
| 2016-06-30 | $65.70M 10-K · filed 2017-03-10 |
| 2015-06-30 | $478.80M 10-K · filed 2016-03-15 |
| 2014-06-30 | $150.30M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |